Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Syphilis Update: Trends, Clinical Presentations, and Advances in Testing and Treatment

Description

The presentation addresses the concerning rise in syphilis cases in the United States, highlighting how current rates are the highest since the 1960s, particularly affecting both men who have sex with men and increasingly, women. Various social determinants, such as homelessness, substance abuse, and reduced public health efforts due to COVID-19, are contributing to this spike. The speaker outlines typical and atypical clinical presentations of syphilis, emphasizing the need for dermatologists to recognize symptoms associated with severe complications like neurosyphilis. Recent advances in testing and treatment are covered, including current guidelines for screening high-risk populations and the importance of appropriate antibiotics, despite shortages of the main treatment drug, Bicillin LA. The discussion calls for vigilance among healthcare providers to stem the increasing trends, noting the critical role of comprehensive sexual health assessments and the need for better public awareness and healthcare access. Furthermore, updates on syphilis testing methods and potential future vaccine developments are discussed, underscoring the ongoing challenges in managing the infection.

View more

Conclusions

  • Syphilis rates are rapidly increasing in the US, particularly among women and Native American populations.
  • The rise in syphilis cases is linked to significant racial, ethnic, and social disparities.
  • There are many atypical clinical presentations of syphilis, necessitating vigilance in diagnosis.
  • Neurosyphilis and ocular syphilis can occur at any stage of the disease and must be assessed for in patients.
  • Testing and screening guidelines for syphilis have been reaffirmed, emphasizing the importance of targeting high-risk groups.
  • There is currently a shortage of essential treatments for syphilis, impacting patient care.
  • Public health resources for STD prevention have been significantly impacted by the COVID-19 pandemic.
  • Advancements in testing and treatment for syphilis are being developed, including potential point-of-care tests and vaccines.
  • Cossman JP, Fournier JB. Frequency of Syphilis Diagnoses by Dermatologists. JAMA Dermatol. 2017;153(7):718-719. doi:10.1001/jamadermatol.2017.0460
  • Hicks CB. Diagnostic Testing for Syphilis. UpToDate.com. Accessed 2/20/2017.
  • Amerson EH, Castillo Valladares HB, Leslie KS. Resurgence of Syphilis in the US-USPSTF Reaffirms Screening Guidelines. JAMA Dermatology. November 2022; 158(11).
  • Oliver SE, Aubin M, Atwell L, et al. Ocular Syphilis - Eight Jurisdictions, United States, 2014-2015. MMWR / November 4, 2016 / Vol. 65 / No. 43.
  • Lithgow KV, Hof R, Wetherell C, et al. A defined syphilis vaccine candidate inhibits dissemination of Treponema pallidum subspecies pallidum. Nature Communications. Received 3 Aug 2016, Accepted 14 Dec 2016, Published 1 Feb 2017. doi:10.1038/ncomms14273.
  • Junejo MH, Collery M, Whitlock G, et al. Treponema pallidum PCR testing for diagnosis of mucocutaneous ulcers suspicious for syphilis. Sex Transm Infect 2021;0:1-3. doi:10.1136/
  • Tuddenham S, et al. JAMA 2022.